A 31P-magnetic resonance spectroscopy and biochemical study of the mo(vbr) mouse: Potential model for the mitochondrial encephalomyopathies

Muscle and Nerve

Volumn 20, Issue 11, 1997, Pages 1352-1359

  Tracey, Irene ^a,b   Dunn, Jeff F ^a   Radda, George K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

31P magnetic resonance spectroscopy; Encephalopathy; Mitochondrial; Mo(vbr); Muscle

Indexed keywords

CREATINE PHOSPHATE; CYTOCHROME C OXIDASE; SUCCINATE DEHYDROGENASE; PHOSPHORUS;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENCEPHALOMYOPATHY; ENZYME ANALYSIS; EXERCISE; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; ANIMAL; ANIMAL DISEASE; DISEASE MODEL; GENETICS; METABOLISM; MITOCHONDRIAL ENCEPHALOMYOPATHY; MOTOR ACTIVITY; MOUSE MUTANT; MUSCLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; RODENT DISEASE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, MUTANT STRAINS; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MOTOR ACTIVITY; MUSCLES; PHOSPHORUS; RODENT DISEASES;

EID: 0030613530     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199711)20:11<1352::AID-MUS2>3.0.CO;2-9     Document Type: Article

References (20)

1. Argov Z, Bank WJ, Maris J, Peterson P, Chance B: Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 1987;37:257-262.
2. 31P NMR. Magn Reson Med 1984;1:307-315.
3. Arnold DL, Taylor DJ, Radda GK: Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196.
4. 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J Cereb Blood Flow Metab 1993;13:469-474.
5. Bergmeyer HV: Methods of Enzymatic Analysis. New York, Academic Press, 1974.
6. Bindoff LA, Birch-Machin MA, Cartlidge NEF, Parker WD Jr, Turnbull DM: Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci 1991;104:203-208.
7. 31P-NMR to clinical biochemistry. Ann NY Acad Sci 1984;428:318-332.
8. Conn RB Jr: Fluorimetric determination of creatine. Clin Chem 1960;6:537-548.
9. Cooper JM, Petty RKH, Hayes DJ, Challiss RA, Brosnan MJ, Shoubridge EA, Radda GK, Morgan-Hughes JA, Clark JB: An animal model of mitochondrial myopathy: a biochemical and physiological investigation of rats treated in vivo with the NADH-CoQ reductase inhibitor, diphenyleneiodonium. J Neurol Sci 1988;83:335-347.
10. Cooper JM, Hayes DJ, Challiss RA, Morgan-Hughes JA, Clark JB: Treatment of experimental NADH ubiquinone reductase deficiency with menadione. Brain 1992;115:991-1000.
11. Danks DM, Campbell PE, Stevens BJ, Mayne V, Cartwright E: Menke's kinky hair syndrome. An inherited defect in copper absorption with widespread effects. Pediatrics 1972;50:188-201.
12. Dunn JF, Frostick S, Brown G, Radda GK: Energy status of cells lacking dystrophin: an in vivo/in vitro study of mdx mouse skeletal muscle. Biochim Biophys Acta 1991;1096:115-120.
13. 31P]-nuclear magnetic resonance study of mdx mice. Proc R Soc Lond B Biol Sci 1993;251:201-206.
14. Eleff S, Barker P, Blackband S, Chatham JC, Lutz NW, Johns DR, Bryan RN: Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol 1990;27:626-630.
15. Fukuhara N: MERRF: a clinicopathological study. Relationships between myoclonus epilepsies and mitochondrial myopthies. Rev Neurol (Paris) 1991;147:476-479.
16. 31P NMR, in Nuccitelli R, Deamer DW (eds): Intracellular pH: Its Measurement, Regulation and Utilization in Cellular Functions. New York, Liss, 1982.
17. Hayasaka K, Brown GK, Danks MD, Kadenbach B: Cytochrome C oxidase deficiency in subacute necrotizing encephalopathy (Leigh syndrome). J Inherit Metab Dis 1989;12:247-256.
18. 31P magnetic resonance and biochemical investigation. J Neural Sci 1985;71:105-118.
19. Higuchi I, Takahashi K, Nakahara K, Izumo S, Nakagawa M, Osame M: Experimental germanium myopathy. Acta Neuropathol (Berl) 1991;82:55-59.
20. Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719.